Thank you for applying to NeuMoDx™ Molecular

Thanks for taking the time to apply. We appreciate your interest in NeuMoDx™ Molecular.

We’re currently in the process of taking applications for this position and will begin taking interviews. If you are selected to continue to the interview process, our recruiting team will be in contact with you.

Thank you!

NeuMoDx™ Molecular Recruiting Team

If you have any questions, please email our team (nhayes@neumodx.com)


Stay Connected!

Don’t forget to follow us on your favorite social media.


We are excited to announce that QIAGEN has acquired all shares of NeuMoDx Molecular, Inc. The addition of NeuMoDx’s medium- and high-throughput molecular systems further expands QIAGEN’s portfolio of molecular diagnostics instruments, bolstering our leadership in automated molecular testing. We are proud to welcome NeuMoDx to our family of PCR solutions that make improvements in life possible.

To learn more, click here.